Silodosin vs naftopidilQoL1 finding from 1 reviewSilodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 652 participantsLow
Silodosin vs alfuzosinQoL1 finding from 1 reviewSilodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 60 participantsModerate
Silodosin vs placeboQoL1 finding from 1 reviewSilodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 820 participantsModerate
Silodosin vs tamsulosinQoL1 finding from 1 reviewSilodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia 2017 · Cochrane Headline outcomes onlyno estimate extracted10 studies · 1707 participantsLow